stockrowINVO Fertility, Inc
IVFINVO Fertility, Inc’s revenue for fiscal 2025 (year ended December 2025) was $6.8 million, up 4.74% from fiscal 2024.
- Revenue
- +16.7%
- EPS
- +100.1%
- Free cash flow
- +35.1%
- Total debt
- −50.7%
Quarter to June 2026, against a year earlier
Follow IVF
Alert me
INVO Fertility, Inc (IVF) EV/Sales
As of 6 November 2026, INVO Fertility, Inc (IVF) trades at a EV/Sales of 0.2×. Over the past ten years it has ranged from 0.1× (November 2026) to 10,140,196,704× (November 2015); the current reading is higher than 0% of that period. That is below the Medical Devices industry median of 2.8× and below the Healthcare sector median of 3.6×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 0.6× | (85.61%) |
| FY2024 | 4.4× | (30.40%) |
| FY2023 | 6.3× | (31.73%) |
| FY2022 | 9.3× | 10.98% |
| FY2021 | 8.4× | (85.50%) |
| FY2020 | 57.7× | 119.04% |
| FY2019 | 26.3× | (100.00%) |
| FY2018 | 115,368,949× | 66.61% |
| FY2017 | 69,243,012× | (92.16%) |
| FY2016 | 883,505,237× | (83.49%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.7× | (9.67%) |
| Mar 2026 | 1.9× | 199.57% |
| Dec 2025 | 0.6× | (60.74%) |
| Sep 2025 | 1.6× | 8.21% |
| 41 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| ICCM IceCure Medical Ltd. compare | −3.8× |
| CODX Co-Diagnostics, Inc. compare | −3.5× |
| AIDX 20/20 Biolabs Inc. compare | −0.7× |
| NUVOQ Holdco Nuvo Group D.G Ltd. compare | n/m |
| BJDX Bluejay Diagnostics, Inc. compare | n/m |
| AMIX Autonomix Medical, Inc. compare | n/m |
| NUWE Nuwellis, Inc. compare | 0.0× |
| IVF INVO Fertility, Inc | 0.2× |
| VVOS Vivos Therapeutics, Inc. compare | 0.4× |
| Medical Devices industry median | 2.8× |
| Healthcare sector median | 3.6× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)